Please use this identifier to cite or link to this item:
|Title:||Synthesis and characterization of diclofenac impurity-A for the quality control of diclofenac and its formulation as per international compendiums|
Sahu, Puran L
|Keywords:||Diclofenac;Diclofenac impurity-A;Indian pharmacopoeia;Non steroidal anti-inflammatory drug;Symptomatic relief|
|Abstract:||Diclofenac is one of the top selling non steroidal anti-inflammatory drug (NSAID). It is available in wide range of dosage form for symptomatic relief of diverse inflammatory conditions. Presence of impurity in drug or drug products is a vital concern now a days for which stringent regulatory guidelines have been implemented to safeguard public health. Under these circumstances, presence of diclofenac impurity-A in diclofenac requires strict quality control to satisfy the specified regulatory limit. Therefore, the objective of the presence study is to synthesize diclofenac impurity-A in the purest form and its subsequent characterization by using a panel of sophisticated analytical techniques to provide as reference standard mentioned in most of the international compendiums including Indian Pharmacopoeia.|
|Appears in Collections:||IJC-B Vol.58B(07) [July 2019]|
Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.